---
figid: PMC6177618__BPH-175-4083-g001
figlink: /pmc/articles/PMC6177618/figure/bph14086-fig-0001/
number: F1
caption: Overview of calcium‐sensing receptor signalling and trafficking. The binding
  of calcium (Ca2+) to the CaS receptor extracellular domain leads to Gα11‐dependent
  activation of PLC‐β and the production of DAG and inositol 1,4,5‐trisphosphate (IP3)
  from membrane‐bound phosphatidylinositol 4,5‐bisphosphate (PIP2). The increase in
  intracellular IP3 levels facilitates the release of Ca2+ from intracellular stores
  such as the ER. DAG activates PKC and the MAPK pathway. These signalling events
  lead to a decrease in PTH secretion and reduction in renal tubular calcium reabsorption
  and also enhance insulin release from pancreatic islets. CaS receptor cell‐surface
  expression is regulated by ADIS (Grant et al., ) and also by an endocytic complex
  comprising clathrin, β‐arrestin and the AP2 complex, which may traffic this GPCR
  to the endosomal–lysosomal degradation pathway or recycle the CaS receptor back
  to the cell surface (Breitwieser, ). Loss‐ and gain‐of function mutations of the
  CaS receptor lead to FHH1 and ADH1, respectively; loss‐ and gain‐of function mutations
  of the Gα11 subunit are associated with FHH2 and ADH2, respectively; and loss‐of‐function
  mutations of the AP2σ lead to FHH3.
pmcid: PMC6177618
papertitle: Calcimimetic and calcilytic therapies for inherited disorders of the calcium‐sensing
  receptor signalling pathway.
reftext: Fadil M Hannan, et al. Br J Pharmacol. 2018 Nov;175(21):4083-4094.
pmc_ranked_result_index: '48031'
pathway_score: 0.9661762
filename: BPH-175-4083-g001.jpg
figtitle: Calcium‐sensing receptor signalling and trafficking
year: '2018'
organisms:
- Homo sapiens
ndex: 85c426ec-ded0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6177618__BPH-175-4083-g001.html
  '@type': Dataset
  description: Overview of calcium‐sensing receptor signalling and trafficking. The
    binding of calcium (Ca2+) to the CaS receptor extracellular domain leads to Gα11‐dependent
    activation of PLC‐β and the production of DAG and inositol 1,4,5‐trisphosphate
    (IP3) from membrane‐bound phosphatidylinositol 4,5‐bisphosphate (PIP2). The increase
    in intracellular IP3 levels facilitates the release of Ca2+ from intracellular
    stores such as the ER. DAG activates PKC and the MAPK pathway. These signalling
    events lead to a decrease in PTH secretion and reduction in renal tubular calcium
    reabsorption and also enhance insulin release from pancreatic islets. CaS receptor
    cell‐surface expression is regulated by ADIS (Grant et al., ) and also by an endocytic
    complex comprising clathrin, β‐arrestin and the AP2 complex, which may traffic
    this GPCR to the endosomal–lysosomal degradation pathway or recycle the CaS receptor
    back to the cell surface (Breitwieser, ). Loss‐ and gain‐of function mutations
    of the CaS receptor lead to FHH1 and ADH1, respectively; loss‐ and gain‐of function
    mutations of the Gα11 subunit are associated with FHH2 and ADH2, respectively;
    and loss‐of‐function mutations of the AP2σ lead to FHH3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TFAP2A
  - CLTB
  - PIR
  - CLTA
  - PRKCA
  - MAPK13
  - ADH4
  - PRKD3
  - MAPK9
  - ADH1A
  - PLCB1
  - MAPK11
  - PRKCD
  - MAPK10
  - GNA11
  - MAPK12
  - MAPK8
  - CLTC
  - MAPK1
  - MAPK3
  - PRKCB
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKCG
  - FH
  - PLCB2
  - PLCB3
  - PRKCH
  - MAPK14
  - PRKCE
  - PLCB4
  - PTH
  - Ca
  - B Ga11
  - pancreatic
genes:
- word: AP2
  symbol: AP-2
  source: hgnc_alias_symbol
  hgnc_symbol: TFAP2A
  entrez: '7020'
- word: Clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTB
  entrez: '1212'
- word: PIR
  symbol: PIR
  source: hgnc_symbol
  hgnc_symbol: PIR
  entrez: '8544'
- word: Clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTA
  entrez: '1211'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ADH2
  symbol: ADH-2
  source: hgnc_alias_symbol
  hgnc_symbol: ADH4
  entrez: '127'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: ADH1
  symbol: ADH1
  source: hgnc_prev_symbol
  hgnc_symbol: ADH1A
  entrez: '124'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: FHH2
  symbol: FHH2
  source: hgnc_alias_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTC
  entrez: '1213'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: FHЗ
  symbol: FH
  source: hgnc_symbol
  hgnc_symbol: FH
  entrez: '2271'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PTH
  symbol: PTH
  source: hgnc_symbol
  hgnc_symbol: PTH
  entrez: '5741'
chemicals:
- word: Ca
  source: MESH
  identifier: D002118
- word: B Ga11
  source: MESH
  identifier: C043055
diseases:
- word: pancreatic
  source: MESH
  identifier: D010195
figid_alias: PMC6177618__F1
redirect_from: /figures/PMC6177618__F1
figtype: Figure
---
